Modifications of IL-6 by Hypochlorous Acids: Effects on Receptor Binding

[Image: see text] Interleukin-6 (IL-6) has been implicated in the pathogenesis of inflammatory events including those seen with COVID-19 patients. Positive clinical responses to monoclonal antibodies directed against IL-6 receptors (IL-6Rs) suggest that interference with IL-6-dependent activation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Robins, Lori I., Keim, Erika K., Robins, Deborah B., Edgar, John S., Meschke, John S., Gafken, Philip R., Williams, Jeffrey F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717532/
https://www.ncbi.nlm.nih.gov/pubmed/34984290
http://dx.doi.org/10.1021/acsomega.1c05297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717532/
https://www.ncbi.nlm.nih.gov/pubmed/34984290
http://dx.doi.org/10.1021/acsomega.1c05297

Ejemplares similares